Last updated: October 11, 2023
Sponsor: MaxWell Clinic, PLC
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT06079827
FBB-PE-003
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Subject is scheduled to undergo their first TPE Procedure for a diagnosis ofAlzheimer's Disease or previous mental/cognitive impairment
- Mentally capable of understanding and completing informed consent for the study.
Exclusion
Exclusion Criteria:
- Subject is unable or failed to return/provide blood specimen on days seven (7),fourteen (14) , twenty-one (21), and twenty-eight (28) (plus or minus 1 day on followup draws) post plasma exchange
- Subject is unable to provide informed consent.
Study Design
Total Participants: 43
Study Start date:
March 22, 2022
Estimated Completion Date:
September 01, 2025
Study Description
Connect with a study center
The MaxWell Clinic
Brentwood, Tennessee 37027
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.